Evidence map›Paper›PMID 41529023›Full record

ArticlePloS one2026

Consumer preferences for the development of new emulsion products based on vegetable and animal fats.

Małgorzata Kowalska, Magdalena Woźniak, Krzysztof Golec, Anna Zbikowska, Jerzy Szakiel, Paweł Turek

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Małgorzata KowalskaCasimir Pulaski Radom University, Radom, Poland.
Magdalena WoźniakMedicofarma S.A., Warsaw, Poland.
Krzysztof GolecCasimir Pulaski Radom University, Radom, Poland.
Anna ZbikowskaWarsaw University of Life Sciences-SGGW (WULS-SGGW), Warsaw, Poland.
Jerzy SzakielKrakow University of Economics, Krakow, Poland.ORCID https://orcid.org/0000-0002-1455-1132
Paweł TurekKrakow University of Economics, Krakow, Poland.ORCID https://orcid.org/0000-0002-1804-3223

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this paper was to determine consumer preferences for the acceptance of a new emulsion product containing interesterified fat based on mutton tallow and hemp oil. The survey concerned consumers' reference to the new emulsion products as pharmaceutical, food, and cosmetic products. On the basis of the survey, it was concluded that the hypothetical emulsion products would gain consumer acceptance. Acquisition of this knowledge forms the basis for making decisions regarding the implementation of further experimental work, the outcome of which will be the evaluation of the properties of prototype products, including a comparative assessment of the sensory characteristics of prototypes and market products. More than half of the respondents answered that they would be interested in a new emulsion product based on interesterified fat. The most important factors indicated by the respondents that would lead them to purchase cosmetic or pharmaceutical emulsions were improvement in skin condition after application and the possibility of testing a free sample in advance. In the case of a food emulsion containing modified mutton tallow and hemp oil, on the other hand, the most important factors determining a potential purchase were the opportunity to try a free sample of the product in advance and attributes such as taste and texture that corresponded to the respondents.

Indexed as

Consumer BehaviorFatsVegetablesAnimalsCannabisCosmeticsEmulsionsFemaleHumansMalePlant ExtractsPlant OilsCosmeticsEmulsionsFatshempseed oilPlant ExtractsPlant Oilstallow

Identifiers

PMID41529023
PMCPMC12798963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.